Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus

NCT01958320 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

202

Enrollment

OTHER

Sponsor class

Conditions

Patent Ductus Arteriosus
Surgery
Necrotizing Enterocolitis
Intestinal Perforation

Interventions

OTHER: pharmacologic treatment of the PDA
OTHER: no pharmacologic treatment of the PDA
DRUG: NSAID

Sponsor

University of California, San Francisco